Krystal Biotech, Inc.

Krystal Biotech, Inc.verified

KRYS

Price:

$207.415

Market Cap:

$5.92B

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syn...[Read more]

Industry

Biotechnology

IPO Date

2017-09-20

Stock Exchange

NASDAQ

Ticker

KRYS

The PE Ratio as of July 2024 (TTM) for Krystal Biotech, Inc. (KRYS) is 95.58

According to Krystal Biotech, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 95.58. This represents a change of -73.14% compared to the average of 355.84 of the last 4 quarters.

Krystal Biotech, Inc. (KRYS) Historical PE Ratio (quarterly & annually)

How has KRYS PE Ratio performed in the past?

The mean historical PE Ratio of Krystal Biotech, Inc. over the last ten years is 15.27. The current 95.58 PE Ratio has changed 62.49% with respect to the historical average. Over the past ten years (40 quarters), KRYS's PE Ratio was at its highest in in the March 2024 quarter at 1.34K. The PE Ratio was at its lowest in in the December 2019 quarter at -44.82.

Quarterly (TTM)
Annual

Average

15.27

Median

-21.85

Minimum

-46.13

Maximum

308.15

Krystal Biotech, Inc. (KRYS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Krystal Biotech, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 200.26%

Maximum Annual PE Ratio = 308.15

Minimum Annual Increase = -2235.92%

Minimum Annual PE Ratio = -46.13

Quarterly (TTM)
Annual
YearPE RatioChange
2023308.15-2235.92%
2022-14.43-35.36%
2021-22.32-36.31%
2020-35.04-24.04%
2019-46.13115.79%
2018-21.38200.26%
2017-7.12-82.00%

Krystal Biotech, Inc. (KRYS) Average PE Ratio

How has KRYS PE Ratio performed in the past?

The current PE Ratio of Krystal Biotech, Inc. (KRYS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

90.47

5-year avg

38.05

10-year avg

15.27

Krystal Biotech, Inc. (KRYS) PE Ratio vs. Peers

How is KRYS’s PE Ratio compared to its peers?

Krystal Biotech, Inc.’s PE Ratio is greater than MeiraGTx Holdings plc (-4.02), greater than Apellis Pharmaceuticals, Inc. (-11.03), greater than Deciphera Pharmaceuticals, Inc. (-11.74), greater than REGENXBIO Inc. (-2.41), greater than Rhythm Pharmaceuticals, Inc. (-10.80),

Build a custom stock screener for Krystal Biotech, Inc. (KRYS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Krystal Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Krystal Biotech, Inc. (KRYS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Krystal Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Krystal Biotech, Inc.'s PE Ratio?

How is the PE Ratio calculated for Krystal Biotech, Inc. (KRYS)?

What is the highest PE Ratio for Krystal Biotech, Inc. (KRYS)?

What is the 3-year average PE Ratio for Krystal Biotech, Inc. (KRYS)?

What is the 5-year average PE Ratio for Krystal Biotech, Inc. (KRYS)?

How does the current PE Ratio for Krystal Biotech, Inc. (KRYS) compare to its historical average?